Halozyme Therapeutics (HALO) Return on Capital Employed Growth (5y) (2016 - 2026)
Halozyme Therapeutics (HALO) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,132.22 Bn | 67,131.94 Bn | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.60 Bn | 466.80 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.71 Bn | 114.46 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.83 Bn | 61.07 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn |
| 10 | Halozyme Therapeutics | 9.68 Bn | 9.36 Bn | 297.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -687.00 |
| Dec 31, 2025 | -8,911.00 |
| Sep 30, 2025 | 4,977.00 |
| Jun 30, 2025 | 4,055.00 |
| Mar 31, 2025 | 4,533.00 |
| Dec 31, 2024 | 4,593.00 |
| Sep 30, 2024 | 3,710.00 |
| Jun 30, 2024 | 3,538.00 |
| Mar 31, 2024 | 3,732.00 |
| Dec 31, 2023 | 4,351.00 |
| Sep 30, 2023 | 23.00 |
| Jun 30, 2023 | -690.00 |
| Mar 31, 2023 | -720.00 |
| Dec 31, 2022 | -1,083.00 |
| Sep 30, 2022 | 4,168.00 |
| Jun 30, 2022 | 6,740.00 |
| Mar 31, 2022 | 8,128.00 |
| Dec 31, 2021 | 6,512.00 |
| Sep 30, 2021 | 5,324.00 |
| Jun 30, 2021 | 5,078.00 |